1. Home
  2. RDNW vs VYGR Comparison

RDNW vs VYGR Comparison

Compare RDNW & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RideNow Group Inc.

RDNW

RideNow Group Inc.

HOLD

Current Price

$5.32

Market Cap

213.0M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

193.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDNW
VYGR
Founded
2013
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.0M
193.5M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
RDNW
VYGR
Price
$5.32
$1.75
Analyst Decision
Hold
Strong Buy
Analyst Count
2
11
Target Price
$8.50
★ $14.89
AVG Volume (30 Days)
46.0K
★ 976.4K
Earning Date
11-10-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.84
N/A
EPS
★ 0.06
N/A
Revenue
★ $1,793,369,000.00
$10,135,000.00
Revenue This Year
$3.88
N/A
Revenue Next Year
$5.55
$129.75
P/E Ratio
$89.00
★ N/A
Revenue Growth
★ 91.10
N/A
52 Week Low
$4.08
$1.68
52 Week High
$8.55
$5.19

Technical Indicators

Market Signals
Indicator
RDNW
VYGR
Relative Strength Index (RSI) 50.97 37.90
Support Level $4.64 N/A
Resistance Level $7.14 $2.29
Average True Range (ATR) 0.38 0.15
MACD 0.06 0.03
Stochastic Oscillator 60.33 31.71

Price Performance

Historical Comparison
RDNW
VYGR

About RDNW RideNow Group Inc.

RideNow Group Inc operates solely as a powersports dealership group. Its offerings include new and pre-owned vehicles such as motorcycles, all-terrain vehicles (ATVs), side-by-side vehicles (SXS), and personal watercraft (PWC). It also sells parts, apparel, and accessories, and provides financing, insurance, and aftermarket products, along with repair and maintenance services. The majority of the company's revenue is derived from powersports vehicle sales, and the rest from parts, service and accessories/merchandise, and finance and insurance products.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: